These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 17623688)

  • 1. Detection of OXA-2 group extended-spectrum-beta-lactamase-producing clinical isolates of Escherichia coli from India.
    Bhattacharjee A; Sen MR; Anupurba S; Prakash P; Nath G
    J Antimicrob Chemother; 2007 Sep; 60(3):703-4. PubMed ID: 17623688
    [No Abstract]   [Full Text] [Related]  

  • 2. Activity in vitro of twelve antibiotics against clinical isolates of extended-spectrum beta-lactamase producing Escherichia coli.
    Sorlózano A; Gutiérrez J; Romero JM; de Dios Luna J; Damas M; Piédrola G
    J Basic Microbiol; 2007 Oct; 47(5):413-6. PubMed ID: 17910106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbapenem-resistant Escherichia coli and Klebsiella pneumoniae isolates from Turkey with OXA-48-like carbapenemases and outer membrane protein loss.
    Gülmez D; Woodford N; Palepou MF; Mushtaq S; Metan G; Yakupogullari Y; Kocagoz S; Uzun O; Hascelik G; Livermore DM
    Int J Antimicrob Agents; 2008 Jun; 31(6):523-6. PubMed ID: 18339523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interplay of efflux, impermeability, and AmpC activity contributes to cefuroxime resistance in clinical, non-ESBL-producing isolates of Escherichia coli.
    Källman O; Giske CG; Samuelsen Ø; Wretlind B; Kalin M; Olsson-Liljequist B
    Microb Drug Resist; 2009 Jun; 15(2):91-5. PubMed ID: 19432520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-level cefepime resistance in Escherichia coli from Singapore producing OXA-1 beta-lactamase.
    Koh TH; Wang G; Koh TY
    Int J Antimicrob Agents; 2008 Apr; 31(4):382-3. PubMed ID: 18178066
    [No Abstract]   [Full Text] [Related]  

  • 6. Fatal infection due to extended-spectrum beta-lactamase-producing Escherichia coli: implications for antibiotic choice for spontaneous bacterial peritonitis.
    Paterson DL; Singh N; Gayowski T; Marino IR
    Clin Infect Dis; 1999 Mar; 28(3):683-4. PubMed ID: 10194100
    [No Abstract]   [Full Text] [Related]  

  • 7. Antimicrobial susceptibility of well-characterised multiresistant CTX-M-producing Escherichia coli: failure of automated systems to detect resistance to piperacillin/tazobactam.
    Pitout JD; Le P; Church DL; Gregson DB; Laupland KB
    Int J Antimicrob Agents; 2008 Oct; 32(4):333-8. PubMed ID: 18701262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalent phenotypes and antibiotic resistance in Escherichia coli and Klebsiella pneumoniae at an Indian tertiary care hospital: plasmid-mediated cefoxitin resistance.
    Shahid M; Malik A; Akram M; Agrawal LM; Khan AU; Agrawal M
    Int J Infect Dis; 2008 May; 12(3):256-64. PubMed ID: 17981482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extended-spectrum beta-lactamases in Escherichia coli isolated from dogs and cats in Rome, Italy, from 2001 to 2003.
    Carattoli A; Lovari S; Franco A; Cordaro G; Di Matteo P; Battisti A
    Antimicrob Agents Chemother; 2005 Feb; 49(2):833-5. PubMed ID: 15673782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of plasmid-mediated multidrug resistance in Escherichia coli and Klebsiella oxytoca isolates from clinical specimens in Japan.
    Ode T; Saito R; Kumita W; Sato K; Okugawa S; Moriya K; Koike K; Okamura N
    Int J Antimicrob Agents; 2009 Oct; 34(4):347-50. PubMed ID: 19560903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of the pharmacodynamic activity of clinically achievable tigecycline serum concentrations against clinical isolates of Escherichia coli with extended-spectrum beta-lactamases, AmpC beta-lactamases and reduced susceptibility to carbapenems using an in vitro model.
    Zhanel GG; Baudry PJ; Tailor F; Cox L; Hoban DJ; Karlowsky JA
    J Antimicrob Chemother; 2009 Oct; 64(4):824-8. PubMed ID: 19643776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CTX-M enzymes are the most common extended-spectrum beta-lactamases among Escherichia coli in a tertiary Greek hospital.
    Pournaras S; Ikonomidis A; Kristo I; Tsakris A; Maniatis AN
    J Antimicrob Chemother; 2004 Aug; 54(2):574-5. PubMed ID: 15215222
    [No Abstract]   [Full Text] [Related]  

  • 13. Cefotaxime and ceftazidime-resistant Escherichia coli isolate producing TEM-15 beta-lactamase from a Tunisian hospital.
    Chouchani C; Ben-Achour N; M'charek A; Belhadj O
    C R Biol; 2007 Aug; 330(8):565-70. PubMed ID: 17637436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emergence of imipenem resistance in clinical Escherichia coli during therapy.
    Oteo J; Delgado-Iribarren A; Vega D; Bautista V; Rodríguez MC; Velasco M; Saavedra JM; Pérez-Vázquez M; García-Cobos S; Martínez-Martínez L; Campos J
    Int J Antimicrob Agents; 2008 Dec; 32(6):534-7. PubMed ID: 18775649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistance to extended-spectrum beta-lactams by the emergence of SHV-12 and the loss of OmpK35 in Klebsiella pneumoniae and Escherichia coli in Malaysia.
    Palasubramaniam S; Muniandy S; Navaratnam P
    J Microbiol Immunol Infect; 2009 Apr; 42(2):129-33. PubMed ID: 19597644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Escherichia coli ST131 producing extended-spectrum β-lactamases plus VIM-1 carbapenemase: further narrowing of treatment options.
    Mantengoli E; Luzzaro F; Pecile P; Cecconi D; Cavallo A; Attala L; Bartoloni A; Rossolini GM
    Clin Infect Dis; 2011 Mar; 52(5):690-1. PubMed ID: 21220769
    [No Abstract]   [Full Text] [Related]  

  • 17. [Investigation of the frequency of extended spectrum beta-lactamases and antibiotic resistance in clinical isolates of Escherichia coli and Klebsiella sp].
    Ekşi F; Ozer G; Balci I
    Mikrobiyol Bul; 2007 Jul; 41(3):447-52. PubMed ID: 17933257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Importation of KPC-2-producing Escherichia coli from India.
    Potron A; Poirel L; Verdavaine D; Nordmann P
    J Antimicrob Chemother; 2012 Jan; 67(1):242-3. PubMed ID: 21969332
    [No Abstract]   [Full Text] [Related]  

  • 19. First case of New Delhi metallo-beta-lactamase 1-producing Escherichia coli infection in Japan.
    Chihara S; Okuzumi K; Yamamoto Y; Oikawa S; Hishinuma A
    Clin Infect Dis; 2011 Jan; 52(1):153-4. PubMed ID: 21148536
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of lower urinary tract infection caused by multidrug-resistant extended-spectrum-beta-lactamase-producing Escherichia coli with amoxicillin/clavulanate: case report and characterization of the isolate.
    Lagacé-Wiens PR; Nichol KA; Nicolle LE; DeCorby M; McCracken M; Mulvey MR; Zhanel GG
    J Antimicrob Chemother; 2006 Jun; 57(6):1262-3. PubMed ID: 16565157
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.